Surviving in the Lymphoma Microenvironment: A Tough Challenge for CAR T-Cells

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Surviving in the Lymphoma Microenvironment: A Tough Challenge for CAR T-Cells

By ImmunoTherapy Bridge 2023 FEATURING Marco Ruella

39 views

January 10, 2024

0 Comments

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

Feat. A. Goodman, A. Jeong, S. Rajeeve

13:07

Moffitt Cancer Center

R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?

Feat. J. Chavez

45:56

Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold

09:18

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Random…

Feat. J. Westin

10:04

Tara Graff

How to Incorporate Bispecific Antibodies Into Your NHL Practice: A P…

20:18

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Will Immune Therapy Replace Transplant in Hematologic Malignancies?

Feat. R. Gale

08:23

Total Health

R/R DLBCL Case Discussion: 81 y/o Male Needing 3rd Line Treatment

Feat. J. Chandler, B. Randolph, M. Onciu

08:51

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Outpatient Management of CAR-T and Bi-Speci…

Feat. R. Bansal

04:08

GRACE

CAR T-Cell Therapy Side Effects for Blood Cancers

Feat. A. Goodman

62:02

UChicago Medicine

New Treatment Strategies in DLBCL

Feat. L. Sehn

09:45

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Therapeutic Options for Pts With Primary …

Feat. M. Kamdar

15:26

Moffitt Cancer Center

R/R DLBCL: Are CAR-Ts Superior to Bispecific Antibodies?

Feat. A. Lazaryan

16:03

SOHO 2023 Eleventh Annual Meeting

SOHO 2023: The New Algorithm for 2L LBCL

Feat. J. Westin

32:52

Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

The Improbable History of CAR T-Cells

Feat. C. June

19:05

International Congress on Cancer Metastasis

Could We Cure Metastatic Breast Cancer?

Feat. L. Pusztai

67:04

European School of Oncology

Basic Principles of Tumor Immunology

Feat. M. van den Broek

18:46

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Feat. C. Jackson

15:24

Michael Soulen

Interventional Delivery of CAR-T Therapy

10:27

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data o…

Feat. J. DiPersio

25:44

Tara Graff

Login

Login

Join VuMedi

Surviving in the Lymphoma Microenvironment: A Tough Challenge for CAR T-Cells

Related Content